Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
British Prime Minister Boris Johnson holds a bottle of the Pfizer-BioNTech vaccine as he visits a COVID-19 vaccination centre in Batley, West Yorkshire, England, on Monday. Photo:Jon Super - WPA Pool/Getty Images
The United Kingdom on Thursday launched a new clinical study to test the effects of mixing COVID-19 vaccines.
Why it matters: Per a statement from Oxford University virologist Matthew Snape, chief investigator of the world-first study: "If we do show that these vaccines can be used interchangeably in the same schedule this will greatly increase the flexibility of vaccine delivery."
- He added it "could provide clues as to how to increase the breadth of protection against new virus strains."
How it works: More than 800 volunteers over 50 years old will be given the Oxford University-AstraZeneca coronavirus vaccine followed by a dose of Pfizer-BioNTech's, or vice-versa, according to the U.K. government statement.
- There will be a four- or 12-week break between doses.
What to watch: The study will run for 13 months, but initial findings are expected to be released in the summer.
What they're saying: "It is also even possible that by combining vaccines, the immune response could be enhanced giving even higher antibody levels that last longer," said deputy chief medical officer Professor Jonathan Van-Tam, the senior responsible officer for the study.
- "Unless this is evaluated in a clinical trial we just won't know."
Of note: The FDA said last month it's following discussions, such as "mixing and matching vaccines in order to immunize more people against COVID-19."
- But "without appropriate data supporting such changes in vaccine administration, we run a significant risk of placing public health at risk, undermining the historic vaccination efforts to protect the population from COVID-19."